Personal tools

Coexpression cluster:C1993: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C1993_CD14_Natural_CD8_Neutrophils_Peripheral_Monocytederived_anaplastic |id=C1993 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C1993_CD14_Natural_CD8_Neutrophils_Peripheral_Monocytederived_anaplastic
|full_id=C1993_CD14_Natural_CD8_Neutrophils_Peripheral_Monocytederived_anaplastic
|id=C1993
|id=C1993
|ontology_enrichment_celltype=CL:0002087!2.08e-35!119;CL:0000738!4.45e-35!140;CL:0000766!6.17e-35!76;CL:0000037!8.06e-35!172;CL:0000566!8.06e-35!172;CL:0002032!1.08e-34!165;CL:0000837!1.08e-34!165;CL:0002194!5.23e-33!63;CL:0000576!5.23e-33!63;CL:0000040!5.23e-33!63;CL:0000559!5.23e-33!63;CL:0002009!3.93e-32!65;CL:0002031!1.64e-31!124;CL:0002057!1.91e-31!42;CL:0000988!2.11e-31!182;CL:0000839!1.29e-30!70;CL:0000763!1.60e-30!112;CL:0000049!1.60e-30!112;CL:0000557!9.20e-30!71;CL:0000860!6.37e-28!45;CL:0002393!5.29e-09!9;CL:0002397!5.29e-09!9;CL:0000084!1.39e-07!25;CL:0000827!1.39e-07!25;CL:0000791!1.86e-07!18;CL:0000789!1.86e-07!18;CL:0002420!1.86e-07!18;CL:0002419!1.86e-07!18;CL:0000790!1.86e-07!18;CL:0000625!6.09e-07!11
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002390!1.83e-34!102;UBERON:0003061!1.83e-34!102;UBERON:0007023!2.94e-34!115;UBERON:0002193!6.17e-32!112;UBERON:0002371!1.09e-24!80;UBERON:0001474!3.78e-21!86;UBERON:0002405!2.78e-19!115;UBERON:0004765!1.67e-16!101;UBERON:0001434!1.67e-16!101;UBERON:0001049!6.93e-16!57;UBERON:0005068!6.93e-16!57;UBERON:0006241!6.93e-16!57;UBERON:0007135!6.93e-16!57;UBERON:0002780!3.19e-13!41;UBERON:0001890!3.19e-13!41;UBERON:0006240!3.19e-13!41;UBERON:0003080!1.32e-12!42;UBERON:0002616!6.57e-12!59;UBERON:0002020!1.67e-10!34;UBERON:0003528!1.67e-10!34;UBERON:0001893!2.07e-10!34;UBERON:0001017!2.95e-10!82;UBERON:0002791!4.65e-10!33;UBERON:0005743!1.54e-09!86;UBERON:0001869!2.22e-09!32;UBERON:0000955!2.31e-09!69;UBERON:0006238!2.31e-09!69;UBERON:0000178!8.10e-09!15;UBERON:0000179!8.10e-09!15;UBERON:0000463!8.10e-09!15;UBERON:0003075!8.77e-09!86;UBERON:0007284!8.77e-09!86;UBERON:0002619!2.13e-08!22;UBERON:0002346!4.59e-08!90;UBERON:0000073!5.60e-08!94;UBERON:0001016!5.60e-08!94;UBERON:0001950!1.47e-07!20;UBERON:0003081!3.23e-07!216
}}
}}

Revision as of 14:18, 21 May 2012


Full id: C1993_CD14_Natural_CD8_Neutrophils_Peripheral_Monocytederived_anaplastic



Phase1 CAGE Peaks

Hg19::chr7:36574748..36574760,-p@chr7:36574748..36574760
-
Hg19::chr7:36574802..36574860,-p@chr7:36574802..36574860
-
Hg19::chr7:36574889..36574906,-p@chr7:36574889..36574906
-
Hg19::chr7:36575072..36575092,-p@chr7:36575072..36575092
-
Hg19::chr7:36575162..36575179,-p@chr7:36575162..36575179
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
nongranular leukocyte2.08e-35119
leukocyte4.45e-35140
myeloid leukocyte6.17e-3576
hematopoietic stem cell8.06e-35172
angioblastic mesenchymal cell8.06e-35172
hematopoietic oligopotent progenitor cell1.08e-34165
hematopoietic multipotent progenitor cell1.08e-34165
monopoietic cell5.23e-3363
monocyte5.23e-3363
monoblast5.23e-3363
promonocyte5.23e-3363
macrophage dendritic cell progenitor3.93e-3265
hematopoietic lineage restricted progenitor cell1.64e-31124
CD14-positive, CD16-negative classical monocyte1.91e-3142
hematopoietic cell2.11e-31182
myeloid lineage restricted progenitor cell1.29e-3070
myeloid cell1.60e-30112
common myeloid progenitor1.60e-30112
granulocyte monocyte progenitor cell9.20e-3071
classical monocyte6.37e-2845
intermediate monocyte5.29e-099
CD14-positive, CD16-positive monocyte5.29e-099
T cell1.39e-0725
pro-T cell1.39e-0725
mature alpha-beta T cell1.86e-0718
alpha-beta T cell1.86e-0718
immature T cell1.86e-0718
mature T cell1.86e-0718
immature alpha-beta T cell1.86e-0718
CD8-positive, alpha-beta T cell6.09e-0711
Uber Anatomy
Ontology termp-valuen
hematopoietic system1.83e-34102
blood island1.83e-34102
adult organism2.94e-34115
hemolymphoid system6.17e-32112
bone marrow1.09e-2480
bone element3.78e-2186
immune system2.78e-19115
skeletal element1.67e-16101
skeletal system1.67e-16101
neural tube6.93e-1657
neural rod6.93e-1657
future spinal cord6.93e-1657
neural keel6.93e-1657
regional part of forebrain3.19e-1341
forebrain3.19e-1341
future forebrain3.19e-1341
anterior neural tube1.32e-1242
regional part of brain6.57e-1259
gray matter1.67e-1034
brain grey matter1.67e-1034
telencephalon2.07e-1034
central nervous system2.95e-1082
regional part of telencephalon4.65e-1033
cerebral hemisphere2.22e-0932
brain2.31e-0969
future brain2.31e-0969
blood8.10e-0915
haemolymphatic fluid8.10e-0915
organism substance8.10e-0915
neural plate8.77e-0986
presumptive neural plate8.77e-0986
regional part of cerebral cortex2.13e-0822
neurectoderm4.59e-0890
regional part of nervous system5.60e-0894
nervous system5.60e-0894
neocortex1.47e-0720
lateral plate mesoderm3.23e-07216


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.